Pendulum Therapeutics Raises $54 million Gut health biotech company Pendulum Therapeutics recently announced a $54 million investment led by Meritech Capital with participation from existing investors including Sequoia Capital, True Ventures and Khosla Ventures.
The Series C round nearly doubled the entirety of Pendulum’s previous raises, bringing the total venture capital raised to $111 million.
As lead investor, Meritech General Partner Craig Sherman will take a seat on the Pendulum Board of Directors alongside Roelof Botha, a partner at Sequoia, and Adam D’Augelli, a partner at True Ventures.
“We think Pendulum is a next generation pharma company doing next generation gene sequencing,” said Sherman.
Roelof-botha
Colleen-cutcliffe
Craig-sherman
Pacific-biosciences
Adam-daugelli
Meritech-general-partner-craig-sherman
Pendulum-board
Adamd-augelli
Pendulum-glucose
Glucose-control
Pendulum-therapeutics
Pandemic impacted our gut health and gut bacteria
Exercise, a healthy diet, being outside helps your gut
Over the last few years, probiotics and gut health have been all the rage in taking care of our microbiome, which is the bacteria living inside of us.
and last updated 2021-04-08 14:34:35-04
Over the last few years, probiotics and gut health have been all the rage in taking care of our microbiome, which is the bacteria living inside of us.
The pandemic has had a negative effect on our microbiome which relies on various diverse bacteria to function properly. Since we haven t traveled, touched people or things that diverse bacteria isn t finding its way into our bodies.
Colleen-cutcliffe
சக-கூட்கலிப்பே